Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older

NCT00741039 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Lung Cancer
Prostate Cancer

Interventions

BIOLOGICAL: inactivated influenza vaccine and the 23- valent pneumococcal vaccine
BIOLOGICAL: inactivated influenza vaccine and the PPV23 vaccine (Pneumovax)

Sponsor

Memorial Sloan Kettering Cancer Center